Comparing a new prostate biopsy system to standard biopsy methods

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the performance of a novel prostate biopsy system, the SUREcore biopsy needle and coreCARE specimen retrieval device, against the standard biopsy needle and typical tissue container used in urology. The study involves obtaining prostate tissue samples from adult males scheduled for biopsy, using a systematic approach to collect samples with both devices. Participants will provide informed consent and will be monitored for adverse events during and after the procedure, while pathologists will assess the quality of the tissue cores obtained.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult male scheduled for prostate biopsy
* Able to provide informed consent
* Able and willing to provide verbal assessment of his condition 5 days post-procedure

Exclusion Criteria:

* Unwilling to provide consent

Where it's running

• Georgia Urology
  Cartersville, Georgia, United States Recruiting

Study contacts

• Study coordinator: Thomas Lawson, PhD
• Email: drthomlawson@gmail.com
• Phone: 5102061794

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Remote robotic prostate surgery using telesurgery technology

  This trial will try using robotic telesurgery—where a specialist operates remotely over a secure internet link—for adults who need robotic prostate surgery.

  Recruiting AdventHealth · Celebration, Florida · NCT07130708

• 68Ga-PSMA-CYC PET imaging for diagnosing, staging, and restaging prostate cancer

  This trial will test a new PET tracer called 68Ga-PSMA-CYC to see if it safely finds and stages prostate cancer in men and how it compares with current PSMA tracers.

  Recruiting Phase 1/2 First Affiliated Hospital of Fujian Medical University · Fuzhou, Fujian · NCT07056790

• Normal PSA levels for trans women and non-binary people with prostates

  This study tests normal PSA reference levels in trans women and non-binary people who have prostates and are 40 or older.

  Recruiting Queen Mary University of London · London · NCT06987045

• Fezolinetant for hot flashes in men receiving androgen-deprivation therapy

  This test will try whether fezolinetant reduces hot flashes in men with prostate cancer who get them from androgen deprivation therapy.

  Recruiting Phase 2 University of Vermont · Burlington, Vermont · NCT06972875

• Evaluating TURP for men with underactive bladder and urinary obstruction

  This study is testing whether a common prostate surgery can help men with weak bladders and urinary blockage feel better and improve their bathroom habits.

  Recruiting Sohag University · Sohag · NCT06944743

• Ultralow-dose PET imaging for PSMA expression in prostate cancer

  This test will try to see if an ultralow-dose PET scan using 18F-DCFPyL can detect PSMA in people with and without prostate cancer while cutting radiation exposure by 10- to 100-fold.

  Recruiting Phase 2 Nuclear Imaging Institute · Englewood, New Jersey · NCT06904313

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.